Aurobindo Pharma Limited has informed the Exchange about Schedule of meet
AUROPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aurobindo Pharma has informed the exchanges that it will hold an earnings call on August 5, 2025, at 8:30 AM IST to discuss its unaudited financial results for the first quarter ended June 30, 2025 (Q1FY26). The call will be conducted via Zoom and requires pre-registration by participants. An earnings presentation will be uploaded to the company's website shortly after the results are announced. The filing was made under SEBI's Listing Obligations and Disclosure Requirements (Regulation 30(2)).
This is a routine scheduling notice and does not directly affect the stock price. However, it signals that Q1FY26 results are imminent, and investors should watch for the earnings release and management commentary on the call for any guidance on revenue, margins, and US business performance.